In August 2024, P&G shares were attracting a larger group of buyers as investors were preparing for an increase in volatility ...

Johnson & Johnson (NYSE: JNJ) stock fell 1.5%, weighed by a hefty dip in sales of its blockbuster psoriasis treatment Stelara ...

Procter & Gamble topped expectations in fiscal 2025's Q2 with strong revenue figures, but it continues to face challenges ...

The organic sales gain included a 3% increase for the Health Care segment. Oral Care organic sales increased low single ...

Market participants were in full risk-on mode Wednesday as an AI-fueled rally in big tech stocks and a batch of upbeat ...

More consumers are purchasing goods in bulk, the retailer says. It's one way shoppers are coping with lingering inflation ...

Procter & Gamble is trading near the top of the Dow Wednesday after the consumer staples giant beat expectations for its ...

Procter & Gamble on Wednesday reported quarterly earnings and revenue that beat analysts' expectations, thanks to growing ...

Barclays analyst Lauren Lieberman maintained a Hold rating on Procter & Gamble (PG – Research Report) today and set a price target of ...

In a report released yesterday, Robert Ottenstein from Evercore ISI maintained a Buy rating on Procter & Gamble (PG – Research Report), ...